Narazaki M - Search Results

1

A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.

Tanaka T, Narazaki M, Ogata A, Kishimoto T. Tanaka T, et al. Among authors: narazaki m. Semin Immunol. 2014 Feb;26(1):88-96. doi: 10.1016/j.smim.2014.01.009. Epub 2014 Mar 1. Semin Immunol. 2014. PMID: 24594001 Review.

2

The molecular biology of interleukin 6 and its receptor.

Kishimoto T, Hibi M, Murakami M, Narazaki M, Saito M, Taga T. Kishimoto T, et al. Among authors: narazaki m. Ciba Found Symp. 1992;167:5-16; discussion 16-23. doi: 10.1002/9780470514269.ch2. Ciba Found Symp. 1992. PMID: 1425018 Review.

3

Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.

Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab M, Yancopoulos GD, Kishimoto T. Taga T, et al. Among authors: narazaki m. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10998-1001. doi: 10.1073/pnas.89.22.10998. Proc Natl Acad Sci U S A. 1992. PMID: 1438305 Free PMC article.

4

Interleukin-6 receptor and signals.

Taga T, Hibi M, Murakami M, Saito M, Yawata H, Narazaki M, Hirata Y, Sugita T, Yasukawa K, Hirano T, et al. Taga T, et al. Among authors: narazaki m. Chem Immunol. 1992;51:181-204. Chem Immunol. 1992. PMID: 1533128 Review. No abstract available.

5

Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.

Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T. Murakami M, et al. Among authors: narazaki m. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11349-53. doi: 10.1073/pnas.88.24.11349. Proc Natl Acad Sci U S A. 1991. PMID: 1662392 Free PMC article.

6

Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.

Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H, Taga T, Kishimoto T. Yasukawa K, et al. Among authors: narazaki m. Immunol Lett. 1992 Feb;31(2):123-30. doi: 10.1016/0165-2478(92)90138-e. Immunol Lett. 1992. PMID: 1740350

7

Interleukin-6 family of cytokines and gp130.

Kishimoto T, Akira S, Narazaki M, Taga T. Kishimoto T, et al. Among authors: narazaki m. Blood. 1995 Aug 15;86(4):1243-54. Blood. 1995. PMID: 7632928 Free article. Review. No abstract available.

8

Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.

Narazaki M, Witthuhn BA, Yoshida K, Silvennoinen O, Yasukawa K, Ihle JN, Kishimoto T, Taga T. Narazaki M, et al. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2285-9. doi: 10.1073/pnas.91.6.2285. Proc Natl Acad Sci U S A. 1994. PMID: 8134389 Free PMC article.

9

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.

Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T. Narazaki M, et al. Blood. 1993 Aug 15;82(4):1120-6. Blood. 1993. PMID: 8353278 Free article.

10

Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal.

Suzuki H, Yasukawa K, Saito T, Narazaki M, Hasegawa A, Taga T, Kishimoto T. Suzuki H, et al. Among authors: narazaki m. Eur J Immunol. 1993 May;23(5):1078-82. doi: 10.1002/eji.1830230515. Eur J Immunol. 1993. PMID: 8477802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters